We use cookies to ensure our site functions properly and to store limited information about your usage. You may give or withdraw consent at any time. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Helping patients make more informed choices about early phase research
Share Helping patients make more informed choices about early phase research on FacebookShare Helping patients make more informed choices about early phase research on X (formerly Twitter)Share Helping patients make more informed choices about early phase research on LinkedinEmail Helping patients make more informed choices about early phase research link
This part of the research has now concluded. Thank you to everyone who visited our project page and contributed.
Does a list of questions and prompts improve the conversation about entering a trial?
Background
Phase I clinical trials of experimental compounds are an option for some cancer patients who have already tried other treatment options. Deciding to enter such a trial is not a straightforward decision for a patient, and this can create anxiety and uncertainty.
A patient will need to weigh up the risks and benefits of taking part in a trial and talk to their health professional about the likely impact on their health, the latest evidence and the chances of success.
Previous research has shown that some key information is either not always clearly communicated or taken on board in initial conversations between patients and professionals, and that some patients may not always ask important questions about the trial.
With that in mind a Question Prompt List (QPL) has been designed with experienced patients. Patients will use the list to ask questions that are important to them during their conversation with a health professional about entering a clinical trial.
We want know if this improves the conversation between patient and health professional.
An improvement in this dialogue as part of the process of a patient consenting to enter a trial may increase the patients understanding, and in turn give confidence that an informed decision has been made.
How can I get involved?
We want your views on the Question Prompt List and we have designed a survey to get your feedback - please see below.
Read about how patients have been involved so far.
The sponsor of the study is The Royal Marsden NHS Foundation Trust.
Does a list of questions and prompts improve the conversation about entering a trial?
Background
Phase I clinical trials of experimental compounds are an option for some cancer patients who have already tried other treatment options. Deciding to enter such a trial is not a straightforward decision for a patient, and this can create anxiety and uncertainty.
A patient will need to weigh up the risks and benefits of taking part in a trial and talk to their health professional about the likely impact on their health, the latest evidence and the chances of success.
Previous research has shown that some key information is either not always clearly communicated or taken on board in initial conversations between patients and professionals, and that some patients may not always ask important questions about the trial.
With that in mind a Question Prompt List (QPL) has been designed with experienced patients. Patients will use the list to ask questions that are important to them during their conversation with a health professional about entering a clinical trial.
We want know if this improves the conversation between patient and health professional.
An improvement in this dialogue as part of the process of a patient consenting to enter a trial may increase the patients understanding, and in turn give confidence that an informed decision has been made.
How can I get involved?
We want your views on the Question Prompt List and we have designed a survey to get your feedback - please see below.
Read about how patients have been involved so far.
The sponsor of the study is The Royal Marsden NHS Foundation Trust.
Share Our work with patients so far on FacebookShare Our work with patients so far on X (formerly Twitter)Share Our work with patients so far on LinkedinEmail Our work with patients so far link
The design and concept of this research including all patient facing documents have been reviewed by the Royal Marsden/Institute of Cancer Research Patient and Carer Research Review Panel.
Patients and the public were involved in the development of the Question Prompt List.
Two focus groups were conducted consisting of 6-8 patients who were currently participating in Phase I trial.
These discussions informed the development of the questions in the prompt, based on what these patients felt was important and what they would have liked to have more information about at the time of their consultation.
The design and concept of this research including all patient facing documents have been reviewed by the Royal Marsden/Institute of Cancer Research Patient and Carer Research Review Panel.
Patients and the public were involved in the development of the Question Prompt List.
Two focus groups were conducted consisting of 6-8 patients who were currently participating in Phase I trial.
These discussions informed the development of the questions in the prompt, based on what these patients felt was important and what they would have liked to have more information about at the time of their consultation.
This part of the research has now concluded. Thank you to everyone who visited our project page and contributed.
Our research question
What is the experience of using a Question Prompt List (QPL) within the phase I clinical trial setting?
